AVITA Medical, Inc. (RCEL) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, AVITA Medical reported revenue of $71.6M, up 11.5% from $64.3M the year before. Net income was -$48.6M (a -67.8% net margin), or -$1.74 per diluted share. Gross margin was 82.1% and operating margin was -59.4%. Operating activities generated -$31.2M of cash, leaving -$32.2M of free cash flow. At fiscal year end, AVITA Medical held $56.4M in total assets against $73.0M in total liabilities, including $10.2M of cash and equivalents.
Open the full interactive AVITA Medical financials → Quarterly statements, key ratios, valuation history and price charts.
AVITA Medical Key Stats
| Share Price | $13.36 |
|---|---|
| Market Cap | $410.8M |
| Revenue YoY Growth | +11.5% |
| 52-Week Range | $3.27 – $13.37 |
| Shares Outstanding | 30.7 million (basic, 2026 Q2) |
AVITA Medical Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $14.3M | $29.2M | $34.4M | $50.1M | $64.3M | $71.6M |
| Gross Profit | $11.3M | $23.3M | $28.4M | $42.4M | $55.2M | $58.8M |
| Operating Income | -$42.7M | -$26.5M | -$27.5M | -$42.7M | -$56.6M | -$42.5M |
| Pre-Tax Income | -$42.0M | -$26.5M | -$26.6M | -$35.3M | -$61.8M | -$48.6M |
| Income Tax | $4,000 | $38,000 | $36,000 | $66,000 | $54,000 | $11,000 |
| Net Income | -$42.0M | -$26.6M | -$26.7M | -$35.4M | -$61.8M | -$48.6M |
| Diluted EPS | $2.07 | $1.17 | $1.07 | $1.40 | -$2.39 | -$1.74 |
AVITA Medical Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $17.1M | $17.6M | $19.3M | $21.7M |
| Net Income | -$13.2M | -$11.6M | -$10.6M | -$7.7M |
| Diluted EPS | -$0.46 | -$0.42 | -$0.35 | -$0.25 |
AVITA Medical Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $73.6M | $110.7M | $18.2M | $22.1M | $14.1M | $10.2M |
| Current Assets | $78.4M | $121.3M | $87.5M | $104.0M | $57.0M | $35.5M |
| Total Assets | $82.5M | $125.5M | $98.3M | $111.6M | $79.7M | $56.4M |
| Current Liabilities | $7.7M | $7.4M | $10.7M | $13.2M | $20.2M | $62.7M |
| Total Long-Term Debt | — | — | — | $39.8M | $42.2M | $43.0M |
| Total Liabilities | $10.1M | $9.8M | $13.0M | $61.9M | $75.0M | $73.0M |
| Shareholders' Equity | $72.4M | $115.7M | $84.7M | $49.1M | $4.5M | -$16.6M |
AVITA Medical Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$22.7M | -$25.9M | -$19.1M | -$38.0M | -$48.9M | -$31.2M |
| Cash From Investing | -$847,000 | -$1.2M | -$19.3M | $1.6M | $37.4M | $12.5M |
| Cash From Financing | $77.1M | $64.0M | $900,000 | $40.4M | $3.5M | $14.9M |
| Free Cash Flow | -$23.3M | -$26.8M | -$19.5M | -$39.4M | -$58.1M | -$32.2M |
Figures from AVITA Medical's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full AVITA Medical financials page for every line item.
AVITA Medical Company Profile
| Ticker | RCEL |
|---|---|
| Exchange | Nasdaq, OTC |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Valencia, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001762303 |
Frequently Asked Questions
What was AVITA Medical's revenue in fiscal 2025?
AVITA Medical (RCEL) reported revenue of $71.6M for fiscal 2025.
What is AVITA Medical's annual revenue history?
AVITA Medical's annual revenue by fiscal year: 2020: $14.3M; 2021: $29.2M; 2022: $34.4M; 2023: $50.1M; 2024: $64.3M; 2025: $71.6M.
What was AVITA Medical's net income in fiscal 2025?
AVITA Medical reported net income of -$48.6M for fiscal 2025.
What was AVITA Medical's earnings per share (EPS) in fiscal 2025?
AVITA Medical's diluted EPS was -$1.74 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did AVITA Medical generate in fiscal 2025?
AVITA Medical generated -$32.2M of free cash flow in fiscal 2025.
What was AVITA Medical's revenue last quarter?
In its most recent reported quarter (2026 Q2), AVITA Medical reported revenue of $21.7M.
How much debt does AVITA Medical have?
AVITA Medical reported $43.0M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of AVITA Medical are outstanding?
AVITA Medical reported a weighted average of 30.7 million basic shares outstanding in 2026 Q2.
What is AVITA Medical's market cap?
Based on its latest closing price, AVITA Medical (RCEL) has a market capitalization of about $410.8M.
When does AVITA Medical's fiscal year end?
AVITA Medical's fiscal year end, as registered with the SEC, is December 31.
Where is AVITA Medical headquartered?
AVITA Medical lists its business address in Valencia, California in its SEC filings.